日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Allogeneic RPE cell suspension manufactured at scale demonstrating preclinical safety and efficacy led to IND approval.

大规模生产的同种异体 RPE 细胞悬液证明了其临床前安全性和有效性,从而获得了 IND 批准

Soundararajan Lalitha, Surendran Harshini, Patlolla Niharika, Battu Rajani, Stoddard Jonathan, Arrizabalaga Sebastian, Liu Zengping, Lingam Gopal, Su Xinyi, Ryals Renee C, Pal Rajarshi

The association of cytokine levels and postnatal factors with retinopathy of prematurity

细胞因子水平和产后因素与早产儿视网膜病变的关系

Yazib, Syatirah Abu; Choo, May May; Khaliddin, Nurliza; Ong, Christine Py; Choo, Yao Mun; Kamar, Azanna Ahmad; Lingam, Gopal G; Kamalden, Tengku A

Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases

视网膜色素上皮细胞移植治疗视网膜退行性疾病的进展

Liu, Hang; Huang, Suber S; Lingam, Gopal; Kai, Dan; Su, Xinyi; Liu, Zengping

Hints for Gentle Submacular Injection in Non-Human Primates Based on Intraoperative OCT Guidance

基于术中OCT引导的非人灵长类动物轻柔黄斑下注射技巧

Tan, Gavin S W; Liu, Zengping; Ilmarinen, Tanja; Barathi, Veluchamy A; Chee, Caroline K; Lingam, Gopal; Su, Xinyi; Stanzel, Boris V

Ocular coloboma-a comprehensive review for the clinician

眼部缺损——临床医生的全面综述

Lingam, Gopal; Sen, Alok C; Lingam, Vijaya; Bhende, Muna; Padhi, Tapas Ranjan; Xinyi, Su

Response to 'Comment on: "Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases"'

对“关于‘使用生物材料持续释放抗 VEGF 治疗视网膜疾病’的评论”的回应

Seah, Ivan; Zhao, Xin Xin; Lin, Qianyu; Liu, Zengping; Su, Steven Zheng Zhe; Yuen, Yew Sen; Hunziker, Walter; Lingam, Gopal; Loh, Xian Jun; Su, Xinyi

A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema

一项关于泪液中microRNA谱预测糖尿病性黄斑水肿患者抗VEGF治疗反应的初步研究

Chan, Hwei Wuen; Yang, Binxia; Wong, Wendy; Blakeley, Paul; Seah, Ivan; Tan, Queenie Shu Woon; Wang, Haofei; Bhargava, Mayuri; Lin, Hazel Anne; Chai, Charmaine Hc; Mangunkusumo, Erlangga Ariadarma; Thet, Naing; Yuen, Yew Sen; Sethi, Raman; Wang, Si; Hunziker, Walter; Lingam, Gopal; Su, Xinyi

Systemic Factors Associated with Treatment Response in Diabetic Macular Edema

糖尿病性黄斑水肿治疗反应相关的系统性因素

Wong, Wendy Meihua; Chee, Caroline; Bhargava, Mayuri; Chai, Charmaine; Lin, Hazel; Zhao, Paul; Ariadarma Mangunkusumo, Erlangga; Naing, Thet; Yuen, Yew Sen; Wong, Tien Yin; Su, Xinyi; Lingam, Gopal

Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases

利用生物材料持续释放抗VEGF药物治疗视网膜疾病

Seah, Ivan; Zhao, Xinxin; Lin, Qianyu; Liu, Zengping; Su, Steven Zheng Zhe; Yuen, Yew Sen; Hunziker, Walter; Lingam, Gopal; Loh, Xian Jun; Su, Xinyi

Correction: Use of biomaterials for sustained delivery for anti-VEGF to treat retinal diseases

更正:使用生物材料持续递送抗 VEGF 药物治疗视网膜疾病

Seah, Ivan; Zhao, Xinxin; Lin, Qianyu; Liu, Zengping; Su, Steven Zheng Zhe; Yuen, Yew Sen; Hunziker, Walter; Lingam, Gopal; Loh, Xian Jun; Su, Xinyi